US 11649237
Substituted imidazo[1,5-a]pyrazines for IRE1 inhibition
granted A61KA61K45/06A61P
Quick answer
US patent 11649237 (Substituted imidazo[1,5-a]pyrazines for IRE1 inhibition) held by The Regents of the University of California expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K45/06, A61P, A61P21/00, A61P25/28